Health Education and Promotion

HEALTH EDUCATION AND HEALTH PROMOTION 

1. Concept of Health

According to the World Health Organization (1948):

Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.

Health also refers to the overall functional and metabolic efficiency of an individual.

Determinants of Poor Health

Major factors affecting health include:

• Malnutrition
• Smoking
• Chewing tobacco or pan masala
• Alcohol consumption
• Unhygienic living conditions
• Illiteracy

Health Promotion

Health promotion aims to improve people's health and quality of life.

According to the World Health Organization (2005):

Health promotion is the process of enabling people to increase control over their health and its determinants and thereby improve their health.

Objectives

• Increase health awareness
• Prevent diseases
• Promote healthy lifestyle practices
• Improve social and environmental conditions affecting health

Skills to Improve Health

Health can be improved through the following practices:

• Personal hygiene
• Social activities
• Stress management

Personal Hygiene

Hygiene refers to practices that maintain cleanliness and prevent disease.

Examples:

• Bathing regularly
• Brushing and flossing teeth
• Washing hands before eating
• Washing fruits before eating
• Cleaning utensils and food preparation areas

These practices reduce infections and maintain overall health.

Social Activity

Social relationships influence both mental and physical health.

Benefits of social participation:

• Increased longevity
• Improved mental health
• Better productivity
• Improved emotional well-being

Volunteering and social services can also improve life satisfaction and reduce stress.

Stress Management

Stress is common in modern life due to work pressure and responsibilities.

Effects of Prolonged Stress

• Depression
• Cognitive impairment
• Psychosomatic diseases
• Premature ageing

Stress Management Techniques

Physical methods

• Relaxation exercises
• Physical activity

Psychological methods

• Meditation
• Positive thinking
• Cognitive therapy

Improving skills such as problem-solving and time management also reduces stress.

Health Promotion in Children

Children require proper care from birth to adolescence for healthy physical and mental development.

Pediatric Age Group

Birth to 14 years.

Major Child Health Promotion Activities

1. Immunization
2. Nutrition
3. Oral hygiene
4. Healthy habits

Immunization

Immunization is the process of strengthening the immune system against infectious diseases.

Vaccines prepare the body to fight infections effectively.

Importance

• Prevents infectious diseases
• Strengthens immunity
• Protects children from serious illnesses

Example Vaccination Schedule

• Birth: Hepatitis B vaccine
• 6–8 weeks: DPT and Polio vaccines
• 3rd and 4th months: Additional vaccine doses
• 13 months: MMR vaccine
• 4–5 years: Booster doses of DPT and MMR

Role of Community Pharmacists in Vaccination

Community pharmacists are often the first point of contact for healthcare advice.

Responsibilities

• Stock vaccines
• Provide vaccination advice
• Refer patients to doctors when necessary
• Spread awareness about immunization

During outbreaks such as Influenza A (H1N1), pharmacists help by:

• Providing disease information
• Conducting health education programs
• Improving community awareness

In some countries like United States, United Kingdom, and Portugal, pharmacists also administer vaccines.

Child Nutrition

Proper nutrition supports growth and development from infancy to adolescence.

Balanced Diet for Children

Includes:

• Fruits and vegetables
• Milk and dairy products
• Meat and fish
• Nuts
• Rice and grains

Daily Calorie Requirement (Children up to 5 years)

Formula:

1000 calories + 100 calories × age in years

Example:

• 1 year child → 1100 calories/day
• 2 year child → 1200 calories/day

Infant Feeding

Breastfeeding is strongly recommended for infants.

Infant Formula

When breastfeeding is not possible, iron-fortified commercial infant formulas may be used.

Benefits:

• Prevents iron deficiency anemia
• Supports healthy development

Parents should consult doctors before choosing formula.

Starting Solid Foods

Solid foods are usually introduced around 4–6 months of age.

First foods include:

• Iron-fortified baby cereals
• Pureed vegetables
• Fruit purees
• Pureed meat or chicken

Foods should be soft and easily digestible.

Oral Health in Children

Dental diseases are common but preventable.

Prevalence

• Dental caries affects many children worldwide.

Prevention

• Regular brushing
• Reduced sugar intake
• Use of fluoride toothpaste

Role of Pharmacist in Oral Health

Pharmacists can:

• Educate about dental hygiene
• Recommend fluoride toothpaste
• Suggest sugar-free medicines
• Encourage dental checkups

They can also refer patients to dentists when necessary.

Healthy Habits in Children

Healthy habits developed in childhood continue throughout life.

Important Habits

1. Hand Washing

• Wash hands before meals
• After using the toilet
• After playing or touching dirty objects

This reduces infection transmission.

2. Adequate Sleep Lack of sleep can cause:

• Poor concentration
• Hyperactivity
• Behavioral problems

3. Healthy Eating Balanced diet supports normal growth.

4. Exercise Children should engage in at least 30 minutes of moderate physical activity daily.

Health Promotion in Pregnant Women

Proper prenatal care ensures maternal and fetal health.

Doctors specializing in Gynecology monitor pregnancy through regular checkups.

Prenatal Care Includes

• Blood pressure measurement
• Blood and urine tests
• Weight monitoring
• Pelvic examination
• Estimation of fetal age

Advice for Pregnant Women

• Balanced diet
• Adequate rest and sleep
• Safe exercise
• Avoid smoking and alcohol
• Avoid unnecessary medications

Goal: safe delivery of a healthy baby.

Breastfeeding

The first milk produced after delivery is colostrum.

Benefits of Colostrum

• Rich in antibodies
• Protects baby from infections

Benefits of Breastfeeding

For baby:

• Improved immunity
• Better growth

For mother:

• Strong bonding with baby
• Reduced risk of breast cancer

Role of Pharmacist in Pregnancy Care

Pharmacists should:

• Provide safe medications
• Educate about drug safety in pregnancy
• Advise on nutrition and lifestyle
• Warn against harmful habits

Some drugs pass into breast milk, so pharmacists must guide breastfeeding mothers on medication safety.

Health Promotion in Geriatrics

The elderly population is increasing due to improved life expectancy. In India, this demographic change is creating new healthcare challenges.

Major health issues include non-communicable diseases (NCDs).

Major NCDs

Common NCDs include:

• Diabetes Mellitus
• Coronary Heart Disease
• Stroke
• Chronic Obstructive Pulmonary Disease

India is often called the “diabetes capital of the world.”

Risk Factors for NCDs

Major risk factors include:

• Tobacco use
• Alcohol consumption
• Unhealthy diet
• Physical inactivity
• Sedentary lifestyle

The World Health Organization recommends life-course health promotion to reduce these risks.

Role of Pharmacist in Geriatric Care

Pharmacists help elderly patients by:

Counseling

• Explaining diseases and medications
• Improving medication adherence

Health Screening

• Monitoring blood pressure
• Checking blood sugar levels

Community Support

• Conducting health education programs
• Organizing senior citizen clubs
• Encouraging healthy lifestyle practices

Medication Review

Pharmacists can identify drug-related problems and coordinate with doctors to improve therapy.

 

 

Roles and Responsibilities of Auditor

Auditor in Clinical Research (ICH-GCP Based Notes)

Definition

An auditor is an independent person appointed by the sponsor (or sometimes by regulatory authorities) to conduct a systematic and in-depth examination of:

• Trial conduct
• Compliance with the protocol
• Compliance with Good Clinical Practice (GCP)
• Standard Operating Procedures (SOPs)
• Applicable regulatory requirements

Audit visits are usually pre-arranged, but may be unannounced in cases of suspected serious GCP violations, fraud, or malpractice.

Regulatory Basis

Audits are guided by:

• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH-GCP)
• U.S. Food and Drug Administration (FDA) regulations
• Other applicable national regulatory authorities

Roles and Responsibilities of an Auditor

Auditors perform different types of audits in clinical trials:

1. Investigational Site Audits

Purpose:

To evaluate:

• Site performance
• Compliance with GCP and protocol
• Adequacy of documentation
• Level of sponsor risk

When Conducted:

• If the sponsor suspects non-compliance
• Before regulatory inspection
• As part of routine quality assurance

Focus Areas:

• Informed consent process
• Source data verification
• Drug accountability
• Protocol deviations
• Investigator qualifications
• Safety reporting

2. Clinical Department / Process Audits

Purpose:

To assess internal clinical trial processes.

Need for These Audits:

• Preparation for regulatory inspection
• Improve effectiveness and efficiency
• Address management concerns
• Evaluate adherence to SOPs

Evaluates:

• Monitoring activities
• Documentation practices
• Communication systems
• Protocol implementation

3. Data Management Audits

Objectives:

• Compare dataset entries with Case Report Forms (CRFs)
• Review data validation programs
• Assess query management system
• Check file structure and dataset merging
• Evaluate security and backup procedures

Key Focus:

• Data integrity
• Accuracy
• Confidentiality
• Audit trails

4. Safety Department Audits

Auditor Reviews:

• Sample of Serious Adverse Events (SAEs)

Checks for:

• Accuracy of reporting and coding
• Timeliness of regulatory submission
• Consistency with adverse event database
• Proper use of safety software systems
• Compliance with pharmacovigilance standards

5. GCP Laboratory Audits

Auditor Ensures:

• Research conducted under proper authority
• Scientific validity of procedures
• Protection of subject rights, safety, and well-being
• Equipment calibration and validation
• Proper sample handling and documentation

6. Sponsor Central File Audits

Includes Inspection of:

• Sponsor Trial Master File (TMF)
• Contract Research Organizations (CROs)

Purpose:

• Verify compliance with regulations
• Ensure completeness of essential documents
• Confirm validity and reliability of submitted data

May Be:

• Pre-inspection audits
• For-cause audits
• Routine internal quality audits

Key Differences (Exam Point – Drug Inspector / Clinical Research)

Feature	Audit	Inspection
Conducted by	Sponsor’s QA or independent auditor	Regulatory authority
Purpose	Quality improvement & compliance check	Regulatory enforcement
Frequency	Planned or for-cause	Often unannounced
Outcome	Audit report & CAPA	Warning letters, penalties

Important Points for Exams

• Auditor must be independent of the clinical trial team.
• Auditor prepares a written audit report.
• Findings require Corrective and Preventive Action (CAPA).
• Audit trail and documentation are critical.
• Subject safety and data integrity are top priorities.

Roles and Responsibilities of Clinical Research Associate

 

Roles and Responsibilities of a Clinical Research Associate (CRA)

1. Site Qualification and Selection

• Review study protocol and sponsor requirements
• Assess site facilities, equipment, staff, and patient population
• Conduct pre-study (qualification) visits
• Prepare and submit site qualification / feasibility reports

2. Study Initiation

• Act as the primary liaison between sponsor/CRO and investigator
• Train investigators and site staff on:
• Study protocol
• GCP requirements
• Adverse Event (AE) and Serious Adverse Event (SAE) reporting
• Case Report Form (CRF) completion
• Ensure all regulatory documents are complete before study start
• Conduct Site Initiation Visit (SIV) and prepare initiation report

3. Monitoring of Clinical Trials

• Perform regular on-site and/or remote monitoring visits
• Verify that the study is conducted according to:
• Approved protocol
• GCP guidelines
• Regulatory requirements
• Sponsor SOPs
• Ensure patient safety and protection of subject rights
• Review informed consent process and documentation
• Verify source data against CRFs for accuracy and completeness
• Detect protocol deviations and ensure corrective actions
• Write monitoring and follow-up visit reports

4. Adverse Event and Safety Management

• Train site staff on AE/SAE reporting requirements
• Monitor and review safety data for accuracy and completeness
• Ensure timely reporting of SAEs to sponsor and ethics committees
• Identify unreported or under-reported adverse events
• Ensure appropriate follow-up information is collected and reported
• Communicate safety updates to investigators as required

5. Data Quality and Integrity

• Verify accuracy, consistency, and completeness of collected data
• Resolve data queries in coordination with site staff
• Ensure proper documentation and record keeping
• Verify investigator files against sponsor records
• Ensure compliance with data protection and confidentiality requirements

6. Investigational Product (IP) Management

• Verify receipt, storage, handling, accountability, and return of IP
• Ensure storage conditions comply with protocol requirements
• Review drug accountability logs and temperature records
• Confirm availability of clinical trial materials at the site

7. Quality Assurance and Compliance

• Ensure adherence to protocol, GCP, regulatory requirements, and SOPs
• Support site during audits and regulatory inspections
• Conduct internal audits if required
• Verify compliance with informed consent procedures
• Ensure procedures for handling SAEs are followed correctly

8. Communication and Coordination

• Serve as the main point of contact between sponsor/CRO and site
• Coordinate with project managers and cross-functional teams
• Maintain effective working relationships with investigators and site staff
• Monitor study timelines and site performance

9. Study Close-Out

• Conduct close-out visits upon study completion or termination
• Ensure all data queries are resolved
• Verify completeness of investigator site files
• Ensure return or destruction of investigational products
• Confirm archiving of essential documents
• Prepare and submit close-out visit reports

Summary

The CRA plays a critical role in ensuring subject safety, data integrity, regulatory compliance, and successful execution of clinical trials across all phases—from site selection to study closure.

 

 

Roles and Responsibilities of Investigator

 

INVESTIGATOR

DEFINITION

An Investigator is a person responsible for the conduct of a clinical trial at a trial site.
If the trial is conducted by a team of individuals at the site, the investigator is the leader of the team and is called the Principal Investigator (PI).

REGULATORY BASIS

According to Food and Drug Administration regulations (21 CFR 312), Indian GCP Guidelines, and International Council for Harmonisation-GCP, sponsors must select appropriately trained, qualified, and experienced investigators.

ROLES AND RESPONSIBILITIES OF AN INVESTIGATOR

1. INITIATING A CLINICAL TRIAL

a) Contracts and Agreements

• Enter into all clinical trial–related agreements (clinical trial agreement, budget, confidentiality agreements).
• Ensure agreements comply with applicable regulatory and ethical requirements.

b) IEC / IRB / EC Approval

• Obtain approval from IEC/IRB/EC before initiating the trial.
• Ensure subject enrollment begins only after written approval.

c) Constituting the Study Team

• Select and supervise:
• Co-investigators
• Clinical Research Coordinator (CRC)
• Study nurse
• Pharmacist (if applicable)
• Ensure all team members are qualified and trained.

d) Planning and Ensuring Resources

• Ensure availability of:

Adequate infrastructure and facilities

• Qualified staff
• Time commitment
• Equipment and trial supplies
• Assess feasibility of conducting the trial at the site.

e) Trial Training

• Attend investigator meetings and protocol training.
• Ensure the study team is adequately trained on:
• Protocol
• SOPs
• Safety reporting
• GCP requirements

2. CONDUCT OF THE TRIAL

• Recruit eligible subjects according to the protocol.
• Obtain freely given informed consent before any trial-related procedure.
• Provide appropriate medical care to trial subjects.
• Ensure strict protocol compliance and adherence to the schedule of events.
• Comply with ICH-GCP and applicable regulatory requirements.
• Maintain proper investigational product (IP) storage, handling, dispensing, and accountability.
• Follow approved randomization and blinding/unblinding procedures.
• Communicate with:
• IEC/IRB/EC
• Sponsor and CRO
• Facilitate:
• Data collection
• Monitoring visits
• Audits and inspections
• Document:
• Protocol deviations
• Violations
• Non-compliance
• Ensure subject confidentiality at all times.
• Maintain financial records and trial-related payments.

3. SITE CLOSURE RESPONSIBILITIES

• Submit final study report to IEC/IRB/EC.
• Provide all required documents and data to the sponsor.
• Return unused investigational product and trial equipment.
• Reconcile grants and financial records.
• Archive essential trial documents for the period specified in:
• Regulations
• Sponsor agreement
• Manage premature termination or suspension of the trial, if applicable, and notify all stakeholders.

 

 

Roles and Responsibilities of Sponsor

 

ROLE AND RESPONSIBILITIES OF CLINICAL TRIAL PERSONNEL

(As per ICH-GCP)

DEFINITION: SPONSOR

Sponsor
A sponsor is an individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical trial, as defined under International Council for Harmonisation-GCP, Food and Drug Administration regulations, and Indian GCP.

ROLES AND RESPONSIBILITIES OF THE SPONSOR

1. Selection of Investigator and Institution/Hospital

• Select qualified, trained, and experienced investigators.
• Ensure institutions/hospitals have adequate infrastructure, staff, and facilities.
• Provide:
• Approved protocol
• Investigator’s Brochure (IB) (current version)
• Confirm investigator’s ability to comply with protocol and GCP.

2. Contracts / Agreements

• Enter into written agreements with investigators and institutions.
• Agreements must clearly define:
• Trial conduct according to approved protocol and IEC approval
• Compliance with sponsor Standard Operating Procedures (SOPs)
• Sponsor’s right to monitor, audit, and inspect
• Financial arrangements and compensation
• Protocol must be signed by both sponsor and investigator as confirmation.

3. Allocation of Duties and Functions

• Identify, define, and allocate all trial-related duties.
• Ensure responsibilities are assigned to qualified personnel.
• Maintain documentation of delegation and oversight.
• Ultimate responsibility always remains with the sponsor, even if duties are delegated.

4. Clinical Trial Management, Data Collection, Handling & Record Keeping

• Continuously review trial progress, including:
• Safety data
• Efficacy endpoints
• Decide whether to continue, modify, or terminate the trial.
• When using electronic data systems, ensure:
• Written SOPs
• Audit trails
• Data security and restricted access
• Adequate backup and data recovery
• Maintain confidentiality of trial data.
• Retain essential sponsor documents as per regulatory timelines.

5. Compensation to Subjects and Investigators

• Ensure compensation for:
• Trial-related injury or death (subjects)
• Investigator payments as per agreement
• Payments must not influence trial conduct or subject safety.

6. Ethics Committee (IEC/IRB) Review Confirmation

• Ensure IEC/IRB approval before trial initiation.
• Obtain and maintain documentation of:
• Initial approval
• Continuing review
• Amendments and protocol deviations

7. Information on Investigational Product (IP)

• Provide sufficient non-clinical and clinical data on IP.
• Ensure information supports safe and proper use of the product.

8. Manufacturing, Packaging, Labeling & Coding of IP

• Ensure IP is manufactured according to GMP.
• Labeling must comply with regulatory requirements.
• Coding systems must allow blinding and emergency unblinding.

9. Supply and Handling of Investigational Product

• Ensure proper:
• Storage
• Distribution
• Accountability
• Maintain records of:
• Shipment
• Dispensing
• Return/destruction

10. Safety Information

• Continuously evaluate safety data.
• Ensure investigators are promptly informed of new safety findings.
• Update Investigator’s Brochure when required.

11. ADR / SAE Reporting

• Ensure timely reporting of:
• Serious Adverse Events (SAEs)
• Suspected Unexpected Serious Adverse Reactions (SUSARs)
• Comply with regulatory timelines and reporting formats.

12. Contract Research Organization (CRO) Management

• Sponsor may transfer duties to a CRO.
• Must:
• Clearly document delegated responsibilities
• Maintain oversight and accountability
• Legal responsibility cannot be transferred.

13. Record Access

• Allow regulatory authorities, IEC, and auditors direct access to trial-related records.
• Ensure subject confidentiality is maintained.

14. Monitoring

• Implement a monitoring plan.
• Ensure:
• Subject safety
• Data accuracy and completeness
• Protocol and GCP compliance

15. Audit

• Conduct independent audits when required.
• Ensure audit findings are documented and corrective actions implemented.

16. Premature Termination or Suspension

• May terminate/suspend trial for:
• Safety concerns
• Lack of efficacy
• Administrative or regulatory reasons
• Notify:
• Investigators
• IEC
• Regulatory authorities
• Provide written explanation.

17. Clinical Trial / Study Reports

• Prepare comprehensive clinical study reports.
• Reports must be accurate, complete, and verifiable.

18. Multicenter Trials

• Ensure:
• Standardized protocol implementation
• Consistent data collection across sites
• Coordinated monitoring and reporting